Cravihenz Tablet

Prezentare produs

About Cravihenz Tablet

Cravihenz Tablet is a medication containing the active ingredient Megestrol. Megestrol is a progestin of the 17α-hydroxyprogesterone group which was, until recently, never marketed or used clinically. It is now used for treatments of disease-related weight loss, endometrial cancer, and breast cancer.

Key Benefits & Uses

• Used for: INDICATIONS AND USAGE Megestrol acetate oral suspension, USP is indicated for the treatment of anorexia, cachexia, or an unexplained, significant.
• Use only as directed on the product label or by a healthcare professional.
• Follow the authorised product information for dosing and duration of use.

Active Ingredient & Action

Megestrol, the active ingredient in Cravihenz Tablet, is the pharmacologically active substance of this product. INDICATIONS AND USAGE Megestrol acetate oral suspension, USP is indicated for the treatment of anorexia, cachexia, or an unexplained, significant weight loss in patients with a diagnosis of acquired immunodeficiency syndrome (AIDS). Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Cravihenz Tablet. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Cravihenz Tablet for extended periods without medical advice.